The Advisory Board provides advice and support about the Institute’s strategic direction and day-to-day matters, usually via email.
Members:
Abel Novoa, President of No Gracias, Spain
Alvaro Atallah, Director, the Brazilian Cochrane Centre
Carl Heneghan, Director, Centre for Evidence-Based Medicine, Oxford, UK
David Hammerstein, Director, Commons Network
Dick Bijl, President, International Society of Drug Bulletins
John Ioannidis, Professor, Stanford University
Juan Ramon Laporte, Founder and Director, Butlletí Groc
Kim Witczak, Consumer Advocate, Los Angeles, California
Margrete Auken, Member of the European Parliament (the Greens)
Peter Wilmshurst, Cardiologist, Shrewsbury, UK
Last updated: 23 October 2019